Christopher B Prentiss - Net Worth and Insider Trading
Christopher B Prentiss Net Worth
The estimated net worth of Christopher B Prentiss is at least $1 Million dollars as of 2024-11-07. Christopher B Prentiss is the CFO of Adamas Pharmaceuticals Inc and owns about 145,017 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $1 Million. Details can be seen in Christopher B Prentiss's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher B Prentiss has not made any transactions after 2021-03-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher B Prentiss
Christopher B Prentiss Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher B Prentiss owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .
Click here to see the complete history of Christopher B Prentiss’s form 4 insider trades.
Insider Ownership Summary of Christopher B Prentiss
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2021-03-22 | Chief Financial Officer |
Christopher B Prentiss Latest Holdings Summary
Christopher B Prentiss currently owns a total of 1 stock. Christopher B Prentiss owns 145,017 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 22, 2021, with a value of $1 Million.
Latest Holdings of Christopher B Prentiss
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2021-03-22 | 145,017 | 8.22 | 1,192,040 |
Holding Weightings of Christopher B Prentiss
Christopher B Prentiss Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher B Prentiss has made a total of 5 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 2,422 shares on March 22, 2021, which brought Christopher B Prentiss around $13,273.
Insider Trading History of Christopher B Prentiss
- 1
Christopher B Prentiss Trading Performance
Christopher B Prentiss Ownership Network
Ownership Network List of Christopher B Prentiss
Ownership Network Relation of Christopher B Prentiss
Christopher B Prentiss Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Christopher B Prentiss is the Chief Financial Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , director & 10 percent owner William W. Ericson , and Chief Executive Officer Neil F. Mcfarlane .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Christopher B Prentiss Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher B Prentiss. You might contact Christopher B Prentiss via mailing address: 1900 Powell Street Suite 750 Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
